“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
with Amgen, GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical ...
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...
Amgen’s stock has been rising consistently, with corrections in between due to pipeline setbacks. Amgen’s key medicines, like Evenity and Repatha, newer medicines like Tavneos and Tezspire and ...
Amgen will now move ahead with a phase 2 programme for AMG 133, as it tries to enter a weight-loss category that has been transformed by the approval of Novo Nordisk’s once-weekly GLP-1 agonist ...
Nov. 13-16 _ DP World Tour Championship, Dubai, United Arab Emirates ...
According to Research by SNS Insider, Advancements in therapeutic innovations and the increasing prevalence of chronic diseases drive robust market growth.Pune, March 18, 2025 (GLOBE NEWSWIRE) -- ...
Patrick Reed took a giant step towards qualifying for The Open but Graeme McDowell’s hopes of winning one of three spots at ...
Golf stars around the world are ready for another busy summer. The Masters at Augusta will be the first Major of the year in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results